Finance

Lists
CNC:NYSE
Centene Corp
USD 64,54
-0,74%
(-0,48) 1D
USD 64,81
+0,42% (+0,27)
After hours
Closed: 8 Okt., 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNC...
Open
USD 64,84
High
USD 65,32
Low
USD 63,35
Mkt. cap
31,88 mjd
Avg. vol.
4,65 m
Volume
3,95 m
52-wk high
USD 69,63
52-wk low
USD 31,63
EPS
-USD 10,44
Beta
1,13
Shares outstanding
494,00 m
No. of employees
61 k
Open
USD 64,84
High
USD 65,32
Low
USD 63,35
Mkt. cap
31,88 mjd
Avg. vol.
4,65 m
Volume
3,95 m
52-wk high
USD 69,63
52-wk low
USD 31,63
EPS
-USD 10,44
Beta
1,13
Shares outstanding
494,00 m
No. of employees
61 k
News stories
From web sources and news partners
Profile
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500. Wikipedia
About Centene Corp
CEOSarah M. London
Employees61,1 k
Founded1984
HeadquartersSt. Louis, Missouri, Verenigde State van Amerika
SectorHealth care provider
Analyst ratings
Based on 15 analysts giving stock ratings to CNC in the past 3 months
Buy
Buy
6
Hold
9
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for CNC in the last 3 months.
Highest
Current USD 64,54
USD 80,00 (+23,95%)
Average
USD 72,64 (+12,55%)
Lowest
USD 65,00 (+0,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lance Wilkes
Bernstein
Buy
Maintained
USD 79,00
+22,4%
10/05/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
USD 80,00
+24%
09/24/2026
Andrew Mok CFA
Barclays
Buy
Maintained
USD 80,00
+24%
09/17/2026
Stephen Baxter
Wells Fargo
Hold
Maintained
USD 69,00
+6,9%
09/15/2026
John Stansel
J.P. Morgan
Hold
Reiterated
USD 67,00
+3,8%
08/20/2026
John Staszak
Argus Research
Buy
Upgraded
USD 80,00
+24%
08/10/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
USD 75,00
+16,2%
07/28/2026
Erin Wright
Morgan Stanley
Hold
Maintained
USD 66,00
+2,3%
07/29/2026
Jason Cassorla
Guggenheim
Hold
Maintained
-
-
07/28/2026
David S Macdonald
Truist Financial
Buy
Reiterated
USD 80,00
+24%
07/29/2026
Ben Hendrix
RBC Capital
Hold
Maintained
USD 71,00
+10%
07/28/2026
A.J. Rice
UBS
Hold
Maintained
USD 70,00
+8,5%
07/29/2026
Michael Ha
Robert W. Baird
Hold
Maintained
USD 66,00
+2,3%
07/29/2026
Ryan Langston
TD Cowen
Hold
Reiterated
USD 65,00
+0,7%
07/30/2026
Joanna Gajuk
Bank of America Securities
Buy
Maintained
USD 74,00
+14,7%
07/17/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
USD 69,00
+6,9%
07/13/2026
George Hill
Deutsche Bank
Buy
Upgraded
USD 80,00
+24%
05/20/2026
Scott Fidel
Goldman Sachs
Sell
Maintained
USD 40,00
-38%
04/29/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
USD 58,00
-10,1%
04/29/2026
David Windley
Jefferies
Hold
Maintained
USD 39,00
-39,6%
04/20/2026
Last report
28 Jul. 2026
Fiscal period
Q2 2026
USD 2,51 / USD 1,08
+132,64%beat
Revenue / Est. (USD)
44,81 mjd / 47,45 mjd
-5,56%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
45,35 mjd
45,09 mjd
45,06 mjd
44,81 mjd
Cost of goods sold
40,90 mjd
41,49 mjd
38,30 mjd
39,03 mjd
Cost of revenue
40,90 mjd
41,49 mjd
38,30 mjd
39,03 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,14 mjd
3,35 mjd
3,38 mjd
3,05 mjd
Operating expense
4,20 mjd
4,45 mjd
4,48 mjd
4,10 mjd
Total operating expenses
45,10 mjd
45,94 mjd
42,78 mjd
43,12 mjd
Operating income
248,00 m
-847,00 m
2,28 mjd
1,68 mjd
Other non operating income
-
-
-
-
EBT including unusual items
-6,67 mjd
-1,54 mjd
2,10 mjd
1,49 mjd
EBT excluding unusual items
78,00 m
-1,02 mjd
2,12 mjd
1,53 mjd
Income tax expense
-42,00 m
-443,00 m
560,00 m
399,00 m
Effective tax rate
0,63%
28,71%
26,68%
26,85%
Other operating expenses
745,00 m
771,00 m
794,00 m
745,00 m
Net income
-6,63 mjd
-1,10 mjd
1,54 mjd
1,09 mjd
Net profit margin
-14,62%
-2,44%
3,42%
2,43%
Earnings per share
0,50
-1,19
3,37
2,51
Interest and investment income
-
-
-
-
Interest expense
-170,00 m
-168,00 m
-164,00 m
-153,00 m
Net interest expenses
-170,00 m
-168,00 m
-164,00 m
-153,00 m
Depreciation and amortization charges
147,00 m
160,00 m
134,00 m
139,00 m
EBITDA
565,00 m
-518,00 m
2,58 mjd
1,98 mjd
Gain or loss from assets sale
-
501,00 m
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme